These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

907 related items for PubMed ID: 32240636

  • 1. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
    Huang F, Zhou P, Wang Z, Zhang XL, Liao FX, Hu Y, Chang J.
    Arch Biochem Biophys; 2020 Jun 15; 686():108351. PubMed ID: 32240636
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
    Liu ZB, Wang JA, Lv RQ.
    Eur Rev Med Pharmacol Sci; 2019 Feb 15; 23(4):1418-1427. PubMed ID: 30840262
    [Abstract] [Full Text] [Related]

  • 3. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
    Yu C, Zhang B, Li YL, Yu XR.
    Biomed Pharmacother; 2018 Sep 15; 105():10-17. PubMed ID: 29807230
    [Abstract] [Full Text] [Related]

  • 4. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
    He R, Wu JX, Zhang Y, Che H, Yang L.
    Eur Rev Med Pharmacol Sci; 2018 Sep 15; 22(18):5857-5866. PubMed ID: 30280767
    [Abstract] [Full Text] [Related]

  • 5. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
    Li YJ, Dong BK, Fan M, Jiang WX.
    Int J Clin Exp Pathol; 2015 Sep 15; 8(10):12410-8. PubMed ID: 26722427
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. TBRG4 Knockdown Suppresses Proliferation and Growth of Human Osteosarcoma Cell Lines MG63 Through PI3K/Akt Pathway.
    Huang F, Liao F, Ma G, Hu Y, Zhang C, Xu P, Xu T, Chang J.
    Onco Targets Ther; 2020 Sep 15; 13():7271-7281. PubMed ID: 32801755
    [Abstract] [Full Text] [Related]

  • 8. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
    Zheng J, Liu C, Shi J, Wen K, Wang X.
    Mol Med Rep; 2022 Feb 15; 25(2):. PubMed ID: 34913077
    [Abstract] [Full Text] [Related]

  • 9. LncRNA MALAT1 Promotes Cancer Metastasis in Osteosarcoma via Activation of the PI3K-Akt Signaling Pathway.
    Chen Y, Huang W, Sun W, Zheng B, Wang C, Luo Z, Wang J, Yan W.
    Cell Physiol Biochem; 2018 Feb 15; 51(3):1313-1326. PubMed ID: 30481748
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
    Dong Y, Liang G, Yuan B, Yang C, Gao R, Zhou X.
    Tumour Biol; 2015 Mar 15; 36(3):1477-86. PubMed ID: 25431257
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation.
    Ma K, Zhang C, Li W.
    Cell Cycle; 2020 Sep 15; 19(18):2327-2339. PubMed ID: 32804027
    [Abstract] [Full Text] [Related]

  • 15. Gamabufotalin suppressed osteosarcoma stem cells through the TGF-β/periostin/PI3K/AKT pathway.
    Ma K, Zhang C, Li W.
    Chem Biol Interact; 2020 Nov 01; 331():109275. PubMed ID: 33010222
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5.
    Zhang Z, Luo G, Yu C, Yu G, Jiang R, Shi X.
    J Cell Physiol; 2019 Aug 01; 234(8):13525-13533. PubMed ID: 30773645
    [Abstract] [Full Text] [Related]

  • 17. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
    Zhang B, Li YL, Zhao JL, Zhen O, Yu C, Yang BH, Yu XR.
    Biomed Pharmacother; 2018 Sep 01; 105():1-9. PubMed ID: 29807229
    [Abstract] [Full Text] [Related]

  • 18. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y, Cheng H, Li W, Wu H, Yang Y.
    Int J Cancer; 2019 Aug 15; 145(4):1068-1082. PubMed ID: 30761524
    [Abstract] [Full Text] [Related]

  • 19. Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP.
    Wang Y, Huang H, Li Y.
    Artif Cells Nanomed Biotechnol; 2019 Dec 15; 47(1):1458-1465. PubMed ID: 31007083
    [Abstract] [Full Text] [Related]

  • 20. The circular RNA circ-ITCH acts as a tumour suppressor in osteosarcoma via regulating miR-22.
    Ren C, Liu J, Zheng B, Yan P, Sun Y, Yue B.
    Artif Cells Nanomed Biotechnol; 2019 Dec 15; 47(1):3359-3367. PubMed ID: 31387405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.